Date of announcement  2019/06/14
Time of announcement  14:18:24
 
Date of events   2019/06/14 
To which item it meets paragraph 21
Statement 
1.Date of the shareholders' meeting resolution:2019/06/14
2.Name and title of the director with permission to engage in competitive conduct:
(1)Alan Wang / Director
(2)Daw-Yi Hsu / Director
(3)Yu-Ling Kuo / Director
(4)Paul Yang / Director
(5)Tyzz-Jiun Duh / Independent Director
(6)Hsing-Cheng  Tai / Independent Director
3.Items of competitive conduct in which the director is permitted to engage:
Engaged in business of other companies that are within or similar to the business scope of CDF.
4.Period of permission to engage in the competitive conduct: Appointment term.
5.Circumstances of the resolution (please describe the results of the voting under Article 209 of the Company Act):Approved by a majority of the shareholders present who represent two-thirds or more
of the total number of its outstanding shares.
6.If the permitted competitive conduct is business of a mainland China area enterprise, the name and title of the director (if it is not business of a mainland China area enterprise, please enter ”not applicable” below):
(1)Daw-Yi Hsu / Director
(2)Yu-Ling Kuo / Director
(3)Paul Yang / Director
7.Company name of the mainland China area enterprise and the director's position in the enterprise:
(1)Daw-Yi Hsu: CPEC Huakai Private Equity (Fujian) Co. Ltd. / Director; CPEC Huachuang Private Equity Fund (Kunshan) Co. Ltd. / Director.
(2)Yu-Ling Kuo: CCB Life Insurance Company Limited / Director
(3)Paul Yang: KKR Asia Limited / Partner & CEO of Greater China; SinoCare Group Holdings Limited / Legal Representative and Executive Director
8.Address of the mainland China area enterprise:
(1)Daw-Yi Hsu / CPEC Huakai Private Equity (Fujian) Co. Ltd.: Room 02/03, 35F, Hengli City Office Tower, No. 128-1, Wusi Road, Fuzhou City, Fujian
(2)Daw-Yi Hsu / CPEC Huachuang Private Equity Fund (Kunshan) Co. Ltd.: Room 1201, No. 1228, Qianjin East Road, Kunshan City, Jiangsu
(3)Yu-Ling Kuo / CCB Life Insurance Company Limited: 29-33/F, CCB Tower, No.99, Yincheng Road, Pudong New District, Shanghai
(4)Paul Yang / KKR Asia Limited: 41F, China World Tower 3, No.1 Jianguomenwai Street, Chaoyang District, Beijing
(5)Paul Yang / SinoCare Group Holdings Limited: Room 201, Building A, No. 1 Qianwan 1st Road, Qianhai Shenzhen-Hong Kong Cooperation Zone, Shenzhen
9.Business items of the mainland China area enterprise:
(1)Daw-Yi Hsu / CPEC Huakai Private Equity (Fujian) Co. Ltd.: Trustee management for non-securities investment and relevant equity investment advisory services.
(2)Daw-Yi Hsu / CPEC Huachuang Private Equity Fund (Kunshan) Co. Ltd.: Trustee management for non-securities investment and relevant equity investment advisory services.
(3)Yu-Ling Kuo / CCB Life Insurance Company Limited: Life insurance serives.
(4)Paul Yang / KKR Asia Limited: Financial services.
(5)Paul Yang / SinoCare Group Holdings Limited: Investment in medical industry.
10.Degree of effect on the Company's finances and business:None.
11.If the director has invested in the mainland China area enterprise, the monetary amount of the director's investment and the director's shareholding ratio:None.
12.Any other matters that need to be specified:None.